Post-trial access to tested interventions: The views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS study

AIDS Research and Human Retroviruses

Volumn 22, Issue 9, 2006, Pages 837-841

  Pace, Christine ^a   Grady, Christine ^a   Wendler, David ^a   Bebchuk, Judith D ^b   Tavel, Jorge A ^c   McNay, Laura A ^c   Forster, Heidi P ^a   Killen, Jack ^a,c   Emanuel, Ezekiel J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; AUSTRALIA; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG RESEARCH; EUROPE; FEMALE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; RESEARCH SUBJECT; RESPONSIBILITY; SELF EVALUATION; SOUTH AMERICA; TELEPHONE; THAILAND;

ADULT; ADVISORY COMMITTEES; AGED; ANTI-HIV AGENTS; CHI-SQUARE DISTRIBUTION; CLINICAL TRIALS; DATA COLLECTION; DRUG COSTS; FEMALE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; PUBLIC OPINION; QUESTIONNAIRES; RESEARCH PERSONNEL; RESEARCH SUBJECTS;

EID: 33751035460     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.837     Document Type: Article

References (11)

1. Council for International Organizations of Medical Sciences (CIOMS): International Ethical Guidelines for Biomedical Research Involving Human Subjects. Council for International Organizations of Medical Sciences, Geneva, 2002.
2. Annas G and Grodin M: Human rights and maternal-fetal HIV transmission prevention trials in Africa. Am J Public Health 1998;88:560-563.
3. Shapiro HT and Mcslin EM: Ethical issues in the design and conduct of clinical trials in developing countries. New Engl J Med 2001;345:139-142.
4. Giantz L, Annas G, Grodin M, and Mariner W: Research in developing countries: Taking benefit seriously. Hastings Center Rep 1998;28:38-42.
5. Macklin R: After Helsinki: Unresolved issues in international research. Kennedy Inst Ethics J 2001;11:17-36.
6. Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries: Ethics. Fair benefits for research in developing countries. Science 2002;299:2133-2134.
7. Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries: Moral standards for research in developing countries: From reasonable availability to fair benefits. Hastings Center Rep 2004;34(3):17-27.
8. McMrllan JR and Conlon C: The ethics of research related to health care in developing countries. J Med Ethics 2004;30:204-206.
9. Emery S, Abrams D, Cooper D, et al.: The evaluation of subcutaneous Proleukin (interleukin-2) in a randomized international trial: Rationale, design, and methods of ESPRIT. Control Clin Trials 2002;23:198-220.
10. National Bioethics Advisory Commission: In: Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries (Shapiro HT, ed.). Vol. I: Report and recommendations of National Bioethics Advisory Committee, April 2001, Chapter 4.
11. Kass N and Hyder A: Attitudes and experiences of U.S. and Developing Country investigators regarding U.S. Human Subjects Regulations. In: Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries (Shapiro HT, ed.). Vol. II: Commissioned paper for the National Bioethics Advisory Commission, May 2001, pp. B-1-B-155.